FDA clears first therapy for rare childhood cancer

United Therapeutics' Unituxin has become the first-ever therapy approved in the US for neuroblastoma, a rare form of cancer that most commonly occurs in young children.

Read more here: http://www.pmlive.com/pharma_news/fda_clears_first_therapy_for_rare_childhood_cancer_675188